Showing results (41-50 of 122) with videos related to
Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|January 22, 2009
Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer: results of a German multicenter observational studyJalid Sehouli, O Camara, M Schmidt, et al.Placenta|August 1, 2007
Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentasU Jeschke, D Mayr, B Schiessl, et al.European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trialsS Mahner, C Eulenburg, A Staehle, et al.Geburtshilfe Und Frauenheilkunde|October 21, 2016
HPV Vaccination: Attitude and Knowledge among German GynecologistsT M Kolben, C Dannecker, K Baltateanu, et al.Anesthesia and Analgesia|October 30, 2001
The effects of different mouth-to-mouth ventilation tidal volumes on gas exchange during simulated rescue breathingA Stallinger, V Wenzel, S Oroszy, et al.Journal of Inherited Metabolic Disease|February 1, 2012
Free asymmetric dimethylarginine (ADMA) is low in children and adolescents with classical phenylketonuria (PKU)M Huemer, B Simma, D Mayr, et al.Wiener Klinische Wochenschrift|January 23, 2002
[Drug therapy in cardiopulmonary resuscitation]V Wenzel, A C Krismer, V D Mayr, et al.Resuscitation|August 6, 2004
Effects of vasopressin on left anterior descending coronary artery blood flow during extremely low cardiac outputViktoria D Mayr, Volker Wenzel, Tilko Müller, et al.Critical Care Medicine|October 19, 2007
Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shockGünter Luckner, Viktoria D Mayr, Stefan Jochberger, et al.Der Anaesthesist|February 20, 2009
[Advanced vasodilatory shock. One-year survival after arginine vasopressin therapy]G Luckner, C Torgersen, V D Mayr, et al.Pageof 13